Connecticut 2017 Regular Session

Connecticut Senate Bill SB00844

Introduced
2/16/17  
Introduced
2/16/17  
Refer
2/16/17  
Refer
2/16/17  
Report Pass
3/22/17  
Refer
3/31/17  
Refer
3/31/17  
Report Pass
4/6/17  
Report Pass
4/6/17  
Engrossed
5/3/17  
Engrossed
5/3/17  
Report Pass
5/5/17  
Report Pass
5/5/17  
Chaptered
5/16/17  
Chaptered
5/16/17  
Enrolled
5/18/17  
Enrolled
5/18/17  
Passed
5/24/17  

Caption

An Act Concerning The Department Of Public Health's Recommendations Regarding Revisions To The Statutes Concerning The Human Immunodeficiency Virus.

Impact

The implementation of this bill will have significant implications for state laws regarding public health and drug use. The bill not only establishes guidelines for syringe exchange programs but also ensures that these programs include educational components about safe practices related to HIV and drug overdose prevention. Additionally, it facilitates the provision of referrals for substance abuse counseling and treatment, reflecting a comprehensive approach to addressing the intertwined issues of drug use and public health.

Summary

Senate Bill No. 844, also known as Public Act No. 17-6, aims to revise the statutes concerning the Department of Public Health's recommendations regarding the human immunodeficiency virus (HIV). The bill mandates that the Department of Public Health establishes syringe exchange services programs aimed at improving health outcomes for people who inject drugs in communities affected by HIV or hepatitis C. This legislation recognizes the need to enhance existing outreach efforts and provide essential support services for prevention and treatment of these diseases.

Sentiment

General sentiment surrounding SB 844 appears to be positive, particularly from public health advocates who believe it is a necessary step toward reducing the transmission of HIV and improving overall community health. However, there remains a level of contention, particularly among those who may have concerns regarding the implications of syringe exchange programs and potential impacts on drug-related behaviors in communities.

Contention

One notable point of contention related to the bill involves the potential stigma surrounding syringe exchange programs. Opponents might argue that these programs could inadvertently encourage drug use or public perception nuances regarding addiction. Supporters argue, conversely, that such programs are vital for decreasing the risks associated with needle-sharing and ensuring safer sanitation practices. The bill’s provisions emphasize a reduction in harm rather than an endorsement of substance use, highlighting a key discussion point in legislative and public spheres.

Companion Bills

No companion bills found.

Previously Filed As

CT HB05290

An Act Concerning Various Revisions To The Public Health Statutes.

CT SB00202

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Prescription Drug Control.

CT HB05235

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Cannabis Regulation.

CT HB05488

An Act Concerning Various Revisions To The Public Health Statutes.

CT HB05293

An Act Concerning The Department Of Developmental Services' Recommendations Regarding Various Revisions To Developmental Services Statutes.

CT HB05291

An Act Concerning The Department Of Public Health's Recommendations Regarding Improved Opioid Monitoring.

CT HB05373

An Act Concerning Various Revisions To Human Services Statutes.

CT HB05365

An Act Concerning Technical Revisions To Statutes Concerning Human Services.

CT HB05223

An Act Concerning Minor Revisions To Agriculture Related Statutes And To Open Space Acquisition Related Statutes.

CT HB05236

An Act Concerning Recommendations By The Department Of Consumer Protection.

Similar Bills

No similar bills found.